HIV-1 tat Protein (1-9)
HIV-1 tat Protein (1-9) occurs extracellularly and has a role in the immunosuppression of non-HIV-1-infected T cells in acquired AIDS. HIV-1 tat Protein (1-9) is an inhibitor of DP IV. HIV-1 tat Protein (1-9) can be synthesized by phase peptide synthesis with Fmoc (N- (9-fluorenyl) methoxycarbonyl) technique using the peptide synthesizer 431A. HIV-1 tat Protein (1-9) can be studied in research on HIV-1[1].
Product Specifications
CAS Number
[200203-20-9]
UNSPSC
12352209
Target
HIV
Related Pathways
Anti-infection
Field of Research
Infection; Inflammation/Immunology
Smiles
O=C(N[C@@H](CC(O)=O)C(N1[C@@H](CCC1)C(N[C@@H](C(C)C)C(N[C@@H](CC(O)=O)C(N2[C@@H](CCC2)C(N[C@@H](CC(N)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCC(O)=O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCSC)N
Molecular Formula
C43H68N10O17S
Molecular Weight
1029.12
References & Citations
[1]Wrenger, S., et al., (1997) . The N-terminal structure of HIV-1 Tat is required for suppression of CD26-dependent T cell growth. The Journal of biological chemistry, 272 (48), 30283–30288.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
